Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interf... von Hughes, Timothy P., Hochhaus, Andreas, Branford, Susan, Müller, Martin C., Kaeda, Jaspal S., Foroni, Letizia, Druker, Brian J., Guilhot, François, Larson, Richard A., O'Brien, Stephen G., Rudoltz, Marc S., Mone, Manisha, Wehrle, Elisabeth, Modur, Vijay, Goldman, John M., Radich, Jerald P.

Volltext

In Regard to Brown and Adler von Rudoltz, Marc S., MD

Volltext

Repression of LKB1 by miR-17∼92 Sensitizes MYC-Dependent Lymphoma to Biguanide Treatment von Izreig, Said, Gariepy, Alexandra, Kaymak, Irem, Bridges, Hannah R., Donayo, Ariel O., Bridon, Gaëlle, DeCamp, Lisa M., Kitchen-Goosen, Susan M., Avizonis, Daina, Sheldon, Ryan D., Laister, Rob C., Minden, Mark D., Johnson, Nathalie A., Duchaine, Thomas F., Rudoltz, Marc S., Yoo, Sanghee, Pollak, Michael N., Williams, Kelsey S., Jones, Russell G.

Volltext

First-in-human study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumors von Janku, Filip, Beom, Seung-Hoon, Moon, Yong Wha, Kim, Tae Won, Shin, Young G., Yim, Dong-Seok, Kim, Gun Min, Kim, Hyo Song, Kim, Sun Young, Cheong, Jae-Ho, Lee, Young Woo, Geiger, Barb, Yoo, Sanghee, Thurston, Archie, Welsch, Dean, Rudoltz, Marc S., Rha, Sun Young

Volltext

Modulation of Oxidative Phosphorylation with IM156 Attenuates Mitochondrial Metabolic Reprogramming and Inhibits Pulmonary Fibrosis von Willette, Robert N, Mangrolia, Parth, Pondell, Stephen M, Lee, Christopher Young Woo, Yoo, Sanghee, Rudoltz, Marc S, Cowen, Benjamin R, Welsch, Dean J

Volltext

Phase 1 Study of Weekly Polyethylene Glycol-Camptothecin in Patients with Advanced Solid Tumors and Lymphomas von POSEY, James A, WASIF SAIF, M, TAKIMOTO, Chris H, TOLCHER, Anthony W, CARLISLE, Ronda, GOETZ, Andrew, RIZZO, Jinee, STEVENSON, Suzanne, RUDOLTZ, Marc S, KWIATEK, Joseph, SIMMONS, Paul, ROWINSKY, Eric K

Volltext

Prognostic factors for local control and survival in T1 squamous cell carcinoma of the glottis von Rudoltz, Marc S., Benammar, Alia, Mohiuddin, Mohammed

Volltext

Abstract CT212: Expanded phase 1/2a study of PLX8394, a novel next generation BRAF inhibitor in patients with advanced, unresectable solid tumors with alterations in BRAF von Janku, Filip, Sherman, Eric, Yaeger, Rona, Parikh, Aparna, Sullivan, Ryan, Feun, Lynn, Fuente, Macarena De La, Tsai, Frank Yung-Chin, Gordon, Michael, Allen, Carl, Rudoltz, Marc S., Balinski, Kathe, Averbuch, Steven, Vidne, Michael, Tarcic, Gabi

Volltext

Phase I study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumors von Rha, Sun Young, Beom, Seung-Hoon, Shin, Young Geun, Yim, Dong-Seok, Moon, Yong Wha, Kim, Tae Won, Kim, Sun Young, Kim, Gun Min, Kim, Hyo Song, Cheong, Jae-Ho, Lee, Young Woo, Geiger, Barbara Jean, Yoo, Sanghee, Rudoltz, Marc S., Janku, Filip

Volltext

High-Dose-Rate Brachytherapy for Primary Carcinomas of the Oral Cavity and Oropharynx von Rudoltz, Marc S., Perkins, Ryan S., Luthmann, Robert W., Fracke, Todd D., Green, Tina M., Moye, Linda, Wludyka, Peter, Choi, Young-Ku, Ackerman, Scot N.

Volltext

Cardiovascular safety profile of VT-464 in patients (pts) with castrate-resistant prostate cancer (CRPC) von Kurman, Michael R, Sager, Philip, Rudoltz, Marc S., Eisner, Joel, Goodman, Daniel, Heyman, Eugene, Salvail, Daniel, Bell, Caroline, Moore, William R.

Volltext

Abstract 3941: TNG908 is an MTAPnull-selective PRMT5 inhibitor that drives tumor regressions in MTAP -deleted xenograft models across multiple histologies von Briggs, Kimberly J., Cottrell, Kevin M., Tonini, Matthew R., Wilker, Erik W., Gu, Lina, Davis, Charles B., Zhang, Minjie, Whittington, Doug, Gotur, Deepali, Goldstein, Matthew J., DiBenedetto, Heather, Rudoltz, Marc S., Huang, Alan, Maxwell, John P.

Volltext

Abstract PR01: Rebastinib, a selective TIE2 kinase inhibitor, decreases TIE2-expressing macrophages, reduces metastasis, and increases survival in murine cancer models von Flynn, Daniel L., Kaufman, Michael D., Leary, Cynthia B., Hood, Molly M., Lu, Wei-Ping, Turner, Benjamin A., Wise, Scott C., Rudoltz, Marc S., Smith, Bryan D.

Volltext

Multiple causes of cerebrovascular events in children with tumors of the parasellar region von RUDOLTZ, M. S, REGINE, W. F, LANGSTON, J. W, SANFORD, R. A, KOVNAR, E. H, KUN, L. E

Volltext

Application of Magnetic Resonance Imaging and Three-Dimensional Treatment Planning in the Treatment of Orbital Lymphoma von Rudoltz, Marc S., M.D, Ayyangar, Komanduri, Ph.D, Mohiuddin, Mohammed, M.D

Volltext

TIE2 METHODS FOR INHIBITING TIE2 KINASE USEFUL IN THE TREATMENT OF CANCER von FLYNN DANIEL L, KAUFMAN MICHAEL D, SMITH BRYAN, RUDOLTZ MARC S

Volltext bestellen

Second malignant neoplasia in patients with T1 glottic cancer treated with radiation von Fujita, Mihoko, Rudoltz, Marc S., Canady, Daniel J., Patel, Pushpa, Machtay, Mitchel, Pittard Ms, Melissa Q., Mohiuddin, Mohammed, Regine, William F.

Volltext

Radiotherapy for merkel cell carcinoma of the skin of the head and neck von Suntharalingam, Mohan, Rudoltz, Marc S., Mendenhall, William M., Parsons, James T., Stringer, Scott P., Million, Rodney R.

Volltext

METHODS FOR INHIBITING TIE2 KINASE USEFUL IN THE TREATMENT OF CANCER von Kaufman, Michael D, Smith, Bryan, Flynn, Daniel L, Rudoltz, Marc S

Volltext bestellen

Does pathologic node status affect local control in patients with carcinoma of the head and neck treated with radical surgery and postoperative radiotherapy? von Rudoltz, Marc S., Benammar, Alia, Mohiuddin, Mohammed

Volltext